ライブ

BioPharma DiveAfter raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets CellNociceptive innervation limits tertiary lymphoid structures to promote lung cancer CellGenome instability triggers intercellular DNA transfer between human cells FierceBiotechWith $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate FierceBiotechLilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues BioPharma DiveBristol Myers deepens AI investment with Anthropic deal BioPharma DiveOorja, run by Acceleron veterans, launches to make new fibrosis drugs Endpoints NewsPfizer's next-gen pneumonia shot beats Prevnar 20; Relay targets $175M Clinical OMICsAnti-Inflammatory Drug Could Help Some People with Depression BioPharma DiveImmunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update FierceBiotechBMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows FierceBiotechIncyte pays Genesis $80M to expand AI-fueled drug discovery pact

Clinical OMICs 2026年5月20日

Carolina Aguilar: Brain-Computer Interfaces that Heal Neural Circuits

In this episode of Behind the Breakthroughs , INBRAIN CEO and co-founder discusses how graphene enabled bidirectional therapeutic brain-computer interfaces (BCI...

In this episode of Behind the Breakthroughs , INBRAIN CEO and co-founder discusses how graphene enabled bidirectional therapeutic brain-computer interfaces (BCIs) that read and write neural signals. The post Carolina Aguilar: Brain-Computer Interfaces that Heal Neural Circuits appeared first on Inside Precision Medicine .